Generalized Anxiety Disorder Market Report 2024–2034: Treatment Advancements, Trends & Forecast Across 7 Major Markets

Delve into the evolving generalized anxiety disorder (GAD) market, valued at USD 1,717.5 million in 2024 across the 7 major markets. Fueled by ongoing advancements in psychotherapeutic and pharmacological treatments, the market is projected to grow at a CAGR of 5.4%, reaching USD 2,751.1 million by 2034. This comprehensive report provides insights into emerging therapies, patient adoption trends, market segmentation, and key regional dynamics. With a rising focus on mental health and innovation in drug development, the GAD market presents significant growth opportunities. A valuable resource for pharmaceutical companies, mental health professionals, and strategic stakeholders aiming to navigate the future of anxiety disorder treatment.